Symbio Holdings Limited

ASX:SYM.AX

2.63 (AUD) • At close February 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q2
Revenue 107.88102.897103.35199.24891.674112.066118.869112.044117.44898.139104.068116.66100.34291.4177.24283.97555.36930.30630.8328.47627.7818.429
Cost of Revenue 93.48391.91591.37684.52677.22993.57398.15795.55370.8362.2969.08282.60168.44864.69151.01561.56137.30916.58217.66817.37916.9611.629
Gross Profit 14.39710.98211.97514.72214.44518.49320.71216.49146.61835.84934.98634.05931.89426.71926.22722.41418.0613.72413.16211.09710.826.8
Gross Profit Ratio 0.1330.1070.1160.1480.1580.1650.1740.1470.3970.3650.3360.2920.3180.2920.340.2670.3260.4530.4270.390.3890.369
Reseach & Development Expenses 7.0456.1417.4433.2056.0192.73502.3792.571.5981.31.131.4771.1312.24800.96900.57800.4920
General & Administrative Expenses 00000007.90421.03417.95515.96315.7513.19512.83311.4369.7877.4286.4120.3410.3410.420.072
Selling & Marketing Expenses 00000000.3720.8320.9121.1380.6220.9110.730.7960.6050.5730.5720.4510.6710.5690.516
SG&A 11.37411.0679.2078.4776.0777.9388.7718.27621.86618.86717.10116.37214.10613.56312.23210.3928.0016.9845.3996.7866.254.332
Other Expenses 0.8290.6480.4240000000000000000000
Operating Expenses 10.54510.4198.7838.4776.0777.9388.7718.27635.10931.22126.12525.47321.6620.00319.61716.49412.5949.4078.4647.857.2485.093
Operating Income 3.8520.5633.1926.2458.36810.55511.9418.2159.355.2758.4528.70510.9766.4726.9175.925.7984.3174.7323.2133.7551.661
Operating Income Ratio 0.0360.0050.0310.0630.0910.0940.10.0730.080.0540.0810.0750.1090.0710.090.070.1050.1420.1530.1130.1350.09
Total Other Income Expenses Net -2.136-0.671-0.86-0.733-1.055-1.313-1.084-2.4220.881-1.1130.043-0.447-0.855-0.083-0.602-0.41-0.5170.0480.0110.045-0.1610.127
Income Before Tax 1.716-0.1082.3325.5127.3139.24210.8575.79310.2314.1628.4958.25810.1216.3896.3155.515.2814.3654.7433.2583.5941.788
Income Before Tax Ratio 0.016-0.0010.0230.0560.080.0820.0910.0520.0870.0420.0820.0710.1010.070.0820.0660.0950.1440.1540.1140.1290.097
Income Tax Expense 0.027-0.1871.031.0412.0362.6372.5942.1093.351.12.692.2042.9161.5281.331.5051.211.2521.340.8830.9560.285
Net Income 1.6890.0790.7974.888.9736.6058.2633.6846.8813.0625.8056.0547.2054.8614.9854.0054.0713.1133.4032.3752.6381.503
Net Income Ratio 0.0160.0010.0080.0490.0980.0590.070.0330.0590.0310.0560.0520.0720.0530.0650.0480.0740.1030.110.0830.0950.082
EPS 0.020.0010.0090.0570.110.0770.0980.0480.0920.0410.0790.0820.0990.0710.0740.0590.0640.0490.0540.0380.0430.026
EPS Diluted 0.020.0010.0090.0570.110.0770.0980.0480.0920.0410.0790.0820.0990.0710.0740.0590.0640.0490.0540.0380.0430.026
EBITDA 13.3059.95114.54114.9117.39619.23720.14116.13211.7399.45310.48211.57512.2598.9058.3198.0526.6864.9725.3183.6184.2251.872
EBITDA Ratio 0.1230.0970.1410.150.190.1720.1690.1440.10.0960.1010.0990.1220.0970.1080.0960.1210.1640.1720.1270.1520.102